Expert Perspective Tumor Board

Virtual Tumor Board

Targeted Oncology presents Expert Perspective Virtual Tumor Board, a video editorial series featuring multi-disciplinary collaboration between professionals reviewing patient cases and discussing diagnoses, biomarker testing, and treatment strategies.


The Role of BCMA-Directed Therapy in Relapsed/Refractory Multiple Myeloma

December 1st 2022

Advances in Targeted Therapies for Non-Small Cell Lung Cancer

November 10th 2022

In this panel discussion, experts review clinical cases of metastatic non-small cell lung cancer (mNSCLC), discuss commonly observed targetable genomic alterations, and share their perspectives on key clinical trial data that could impact treatment decision-making.

Advances in the Diagnosis and Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

September 30th 2022

An expert panel including two hematologist-oncologists and a pathologist center discussion on patient cases to review the optimal identification and management of blastic plasmacytoid dendritic cell neoplasm.

Advances in Frontline Treatment for Advanced Renal Cell Carcinoma

June 30th 2022

Moshe Orenstein, MD, gives a brief overview of an exciting upcoming Targeted Oncology Virtual Tumor Board series titled "Advances in Frontline Treatment for Advanced Renal Cell Carcinoma."

Novel Hormonal Therapies in Prostate Cancer

June 27th 2022

Expert panelists center discussion on real-world patient cases to review key clinical trial data and approaches to the management of prostate cancer.

Hepatocellular Carcinoma Treatment Advances

June 24th 2022

Expert panelists center discussion on patient cases to highlight optimal management strategies in patients with hepatocellular carcinoma.

Targeting PSMA in Prostate Cancer Treatment

June 10th 2022

Experts review prostate cancer clinical cases and discuss approaches to treating patients with PSMA targeted therapies.

Advances in the Treatment of HER2+ Breast Cancer

May 25th 2022

A panel of expert oncologists review three clinical cases to highlight key clinical trial data and optimal approaches to treating patients with HER2+ breast cancer.

Graft versus Host Disease Practice Updates

March 31st 2022

Experts collaborate on 3 patient scenarios to review the current treatment paradigm of graft versus host disease in the context of key clinical trial data.

Practice Updates in HR+ Breast Cancer

February 28th 2022

A panel of breast cancer experts review clinical cases in hormone receptor-positive breast cancer, focusing on the optimal treatment approaches for patients and updates on key clinical trial data.